ARCHIVES

5-Day Strut-based Brachytherapy Produced Low Recurrence Rates

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

ASCO Honors Eight With Special Awards

May 24, 2002

Xgeva Delays Metastases To Bone, Amgen Files To Expand Indication

November 25, 2011

Key Cancer Legislation Remains Unfinished as Congress Departs for Election.

October 6, 2006

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

On Capitol Hill: Funding Outlook Brighter For NIH and NCI as appropriators Provide Increases

October 1, 1999